Maria Dolores Ledesma

2 Patents

• US124851172025

  Compositions and Methods for Activating Signaling Through the CB1 Cannabinoid Receptor for Treating and Preventing Diseases and Disorders Characterized by Abnormal Cellular Accumulation of Sphingolipids Such as Sphingomyelin

  Wylder Nation Foundation

  0 cites
• US120233322024

  Compositions and Methods for Activating Signaling Through the CB1 Cannabinoid Receptor for Treating and Preventing Diseases and Disorders Characterized by Abnormal Cellular Accumulation of Sphingolipids Such as Sphingomyelin

  Wylder Nation Foundation

  0 cites